Healthcare Value Capital’s GSK GSK Stock Holding History

Healthcare Value Capital’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$3.82M	Hold	80,000	–	–	7.54%	2
2021 Q2	$3.98M	Hold	80,000	–	–	7.93%	2
2021 Q1	$3.57M	Hold	80,000	–	–	7.95%	3
2020 Q4	$3.68M	Hold	80,000	–	–	12.4%	2
2020 Q3	$3.76M	Hold	80,000	–	–	12.4%	1
2020 Q2	$4.08M	Hold	80,000	–	–	10.41%	1
2020 Q1	$3.79M	Hold	80,000	–	–	6.37%	2
2019 Q4	$4.7M	Hold	80,000	–	–	13.83%	1
2019 Q3	$4.27M	Sell	80,000 -16,000	-17%	-$823K	7.71%	3
2019 Q2	$4.8M	Buy	96,000 +16,000	+20%	+$803K	9.01%	3
2019 Q1	$4.18M	Hold	80,000	–	–	16.1%	2
2018 Q4	$3.82M	Hold	80,000	–	–	14.85%	3
2018 Q3	$4.02M	Hold	80,000	–	–	9.71%	4
2018 Q2	$4.03M	Buy	80,000 +40,000	+100%	+$2.01M	11.43%	4
2018 Q1	$1.95M	Hold	40,000	–	–	8.12%	5
2017 Q4	$1.77M	Hold	40,000	–	–	5.39%	7
2017 Q3	$2.03M	Buy	+40,000	New	+$2.03M	4.06%	8
2014 Q1	–	Sell	-36,773	Closed	-$2.45M	–	47
2013 Q4	$2.45M	Hold	36,773	–	–	1.8%	18
2013 Q3	$2.31M	Hold	36,773	–	–	2.02%	17
2013 Q2	$2.3M	Buy	+36,773	New	+$2.33M	1.67%	21

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare Value Capital's GSK Position: Q3 2021 in Review

Healthcare Value Capital held its GSK (GSK) position steady in Q3 2021 at 80,000 shares worth $3.82M. The position accounts for 7.54% of the portfolio, ranked #2.

Healthcare Value Capital first reported a position in GSK in Q2 2013 and has held it in 20 quarters since. The position peaked at $4.8M in Q2 2019. 793 funds tracked by Wall St. Rank hold GSK as of Q3 2021.

Healthcare Value Capital held 80,000 shares of GSK worth $3.82M as of Q3 2021.
Healthcare Value Capital left its GSK share count unchanged in Q3 2021.
GSK made up 7.54% of Healthcare Value Capital's portfolio in Q3 2021, its #2 holding.
Healthcare Value Capital first reported a position in GSK in Q2 2013 and has held it in 20 quarters since.
Healthcare Value Capital's GSK position peaked at $4.8M in Q2 2019.
793 funds tracked by Wall St. Rank held GSK as of Q3 2021.

Based on Healthcare Value Capital's 13F filing for Q3 2021, filed 15 Nov 2021.